JP2012519669A - 抗真菌剤を溶解する方法、および爪への塗布に適している、高濃度の抗真菌剤を含む組成物 - Google Patents
抗真菌剤を溶解する方法、および爪への塗布に適している、高濃度の抗真菌剤を含む組成物 Download PDFInfo
- Publication number
- JP2012519669A JP2012519669A JP2011552461A JP2011552461A JP2012519669A JP 2012519669 A JP2012519669 A JP 2012519669A JP 2011552461 A JP2011552461 A JP 2011552461A JP 2011552461 A JP2011552461 A JP 2011552461A JP 2012519669 A JP2012519669 A JP 2012519669A
- Authority
- JP
- Japan
- Prior art keywords
- water
- antifungal agent
- pharmaceutical composition
- terbinafine
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20251609P | 2009-03-06 | 2009-03-06 | |
FR0951416 | 2009-03-06 | ||
FR0951416A FR2942716B1 (fr) | 2009-03-06 | 2009-03-06 | Methode de solubilisation d'agent antifongique et compositions a haute concentration en agent antifongique applicables sur l'ongle |
US61/202,516 | 2009-03-06 | ||
PCT/EP2010/052817 WO2010100252A1 (en) | 2009-03-06 | 2010-03-05 | Method of dissolving antifungal agent, and compositions with a high concentration of antifungal agent, suitable for application to the nail |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2012519669A true JP2012519669A (ja) | 2012-08-30 |
Family
ID=41056884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011552461A Pending JP2012519669A (ja) | 2009-03-06 | 2010-03-05 | 抗真菌剤を溶解する方法、および爪への塗布に適している、高濃度の抗真菌剤を含む組成物 |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP2403476A1 (zh) |
JP (1) | JP2012519669A (zh) |
KR (1) | KR20110121702A (zh) |
CN (1) | CN102341092A (zh) |
AU (1) | AU2010220266A1 (zh) |
BR (1) | BRPI1006666A2 (zh) |
CA (1) | CA2753638A1 (zh) |
FR (1) | FR2942716B1 (zh) |
MX (1) | MX2011009093A (zh) |
RU (1) | RU2011140574A (zh) |
WO (1) | WO2010100252A1 (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090175810A1 (en) | 2008-01-03 | 2009-07-09 | Gareth Winckle | Compositions and methods for treating diseases of the nail |
US8039494B1 (en) | 2010-07-08 | 2011-10-18 | Dow Pharmaceutical Sciences, Inc. | Compositions and methods for treating diseases of the nail |
PL2672962T3 (pl) * | 2011-02-11 | 2015-08-31 | Moberg Pharma Ab | Nowa kompozycja przeciwgrzybicza |
US9446131B2 (en) | 2013-01-31 | 2016-09-20 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US8778365B1 (en) | 2013-01-31 | 2014-07-15 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9452173B2 (en) | 2013-01-31 | 2016-09-27 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9433680B2 (en) | 2013-01-31 | 2016-09-06 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
SG11201602596UA (en) | 2013-10-03 | 2016-04-28 | Dow Pharmaceutical Sciences | Stabilized efinaconazole compositions |
EP3071295A4 (en) | 2013-11-22 | 2017-05-31 | Dow Pharmaceutical Sciences, Inc. | Anti-infective methods, compositions, and devices |
SG11201703184SA (en) * | 2014-10-21 | 2017-05-30 | Hexima Ltd | A method of treatment |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0585929A (ja) * | 1991-03-08 | 1993-04-06 | L'oreal Sa | 爪糸状菌症処置用皮フ病学的組成物中への親水性浸透剤 の使用及び相当する組成物 |
WO2008121709A1 (en) * | 2007-03-30 | 2008-10-09 | Transport Pharmaceuticals, Inc. | Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU219480B (hu) * | 1991-05-23 | 2001-04-28 | Novartis Ag. | Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására |
-
2009
- 2009-03-06 FR FR0951416A patent/FR2942716B1/fr not_active Expired - Fee Related
-
2010
- 2010-03-05 WO PCT/EP2010/052817 patent/WO2010100252A1/en active Application Filing
- 2010-03-05 BR BRPI1006666A patent/BRPI1006666A2/pt not_active Application Discontinuation
- 2010-03-05 MX MX2011009093A patent/MX2011009093A/es unknown
- 2010-03-05 EP EP10707032A patent/EP2403476A1/en not_active Withdrawn
- 2010-03-05 CA CA2753638A patent/CA2753638A1/en not_active Abandoned
- 2010-03-05 AU AU2010220266A patent/AU2010220266A1/en not_active Abandoned
- 2010-03-05 CN CN2010800108976A patent/CN102341092A/zh active Pending
- 2010-03-05 JP JP2011552461A patent/JP2012519669A/ja active Pending
- 2010-03-05 KR KR1020117020728A patent/KR20110121702A/ko not_active Application Discontinuation
- 2010-03-05 RU RU2011140574/15A patent/RU2011140574A/ru unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0585929A (ja) * | 1991-03-08 | 1993-04-06 | L'oreal Sa | 爪糸状菌症処置用皮フ病学的組成物中への親水性浸透剤 の使用及び相当する組成物 |
WO2008121709A1 (en) * | 2007-03-30 | 2008-10-09 | Transport Pharmaceuticals, Inc. | Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug |
Also Published As
Publication number | Publication date |
---|---|
CN102341092A (zh) | 2012-02-01 |
FR2942716B1 (fr) | 2011-04-15 |
MX2011009093A (es) | 2011-09-27 |
RU2011140574A (ru) | 2013-04-20 |
EP2403476A1 (en) | 2012-01-11 |
WO2010100252A1 (en) | 2010-09-10 |
CA2753638A1 (en) | 2010-09-10 |
FR2942716A1 (fr) | 2010-09-10 |
AU2010220266A1 (en) | 2011-09-08 |
BRPI1006666A2 (pt) | 2016-04-19 |
KR20110121702A (ko) | 2011-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2012519669A (ja) | 抗真菌剤を溶解する方法、および爪への塗布に適している、高濃度の抗真菌剤を含む組成物 | |
JP5529539B2 (ja) | 医薬組成物 | |
US10881672B2 (en) | Pharmaceutical tetracycline composition for dermatological use | |
KR20100075476A (ko) | 항진균 조성물 | |
KR20150122719A (ko) | 증진된 생체이용률을 갖는 코르티코스테로이드의 국소 제제 | |
US20120328543A1 (en) | Use of a cationic, advantageously amphoteric, surfactant for the preparation of an antifungal solution that can be applied to the nail | |
JPH0585929A (ja) | 爪糸状菌症処置用皮フ病学的組成物中への親水性浸透剤 の使用及び相当する組成物 | |
CA3020157C (en) | Topical composition comprising tacrolimus | |
US20120309763A1 (en) | Antifungal composition intended to be applied to a perforated nail | |
JPH06211651A (ja) | 爪白癬治療用組成物 | |
JP5033381B2 (ja) | 外用医薬組成物 | |
EP1526849B1 (en) | Topical formulations containing ketoprofen stabilised with sulisobenzone | |
AU2004262934B2 (en) | Topical composition comprising terbinafine and hydrocortisone | |
AU2020236525B2 (en) | Stable topical compositions of Fenoldopam | |
WO2007086582A1 (ja) | 22-オキサ-1α,25-ジヒドロキシビタミンD3を含有する水中油型乳剤性ローション剤およびそれを用いた皮膚疾患の治療方法 | |
US20120309753A1 (en) | Method of dissolving antifungal agent, and compositions with a high concentration of antifungal agent, suitable for application to the nail | |
JP4060347B2 (ja) | 22−オキサ−1α,25−ジヒドロキシビタミンD3を含有する水中油型乳剤性ローション剤 | |
JP7512365B2 (ja) | 油性外用液 | |
JP5460766B2 (ja) | 外用医薬組成物 | |
KR20240139048A (ko) | 피부 질환 치료를 위한 유기 아민 pH 조절제를 갖는 룩소리티닙의 국소 제형 | |
JP2014152135A (ja) | 医薬組成物 | |
KR20240101661A (ko) | 자가 유화 수중유 마이크로에멀젼 또는 나노에멀젼 및 유화 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130723 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140114 |